Interdialytic weight gain in diabetic haemodialysis patients and diabetic control as assessed by glycated haemoglobin

Nephron - Clinical Practice

Volumn 113, Issue 1, 2009, Pages

  Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Diabetes; Haemodialysis; Interdialytic weight gain

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LONG ACTING INSULIN; ORAL ANTIDIABETIC AGENT; SHORT ACTING DRUG; SODIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; WEIGHT GAIN;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIURETICS; DRINKING BEHAVIOR; EDEMA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SYSTOLE; THIRST; WEIGHT GAIN;

EID: 67649859229     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228073     Document Type: Article

References (23)

1. Raimann J, Liu L, Ulloa D, Kotanko P, Levin NW: Consequences of overhydration and the need for dry weight assessment. Contrib Nephrol 2008;161:99-107.
2. Davenport A: Intradialytic complications during hemodialysis. Hemodial Int 2006;10:162-167.
3. Giovannetti S, Barsotti G, Cupisti A, Morelli E, Agostini B, Posella L, Gazzetti P, Dani L, Aloisi M, Antonelli A, et al: Dipsogenic factors operating in chronic uremics on maintenance hemodialysis. Nephron 1994;66:413-420. (Pubitemid 24083585)
4. Jacob S, Locking-Cusolito H: Thirst distress and interdialytic weight gain. How do they relate? CANNT J 2004;14:33-37.
5. Porcu M, Fanton E, Zampieron A: Thirst distress and interdialytic weight gain, a study on a sample of haemodialysis patients. J Ren Care 2007;33:179-181.
6. Turner RC, Holman RR: Lessons from the UK prospective diabetes study. Diabetes Res Clin Pract 1995;(suppl):S151-S157.
7. Davenport A, Cox C, Thuraisingham R: Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int 2008;73:759-764. (Pubitemid 351323255)
8. Ramdeen G, Tzamaloukas AH, Malhotra D, Leger A, Murata GH: Estimates of interdialytic sodium and water intake based on the balance principle. Differences between nondiabetic and diabetic subjects on haemodialysis. ASAIO J 1998;44:812-817.
9. Davenport A, Cox C, Thuraisingham R: Blood pressure control and symptomatic intradialytic hypotension in diabetic haemodialysis patients: a cross sectional survey. Nephron Clin Pract 2008;109:c65-c71.
10. The DCCT Research Group: Feasibility of centralized measurements of glycated haemoglobin in the Diabetes Control and Complications Trial: a multicenter study. Clin Chem 1987;33:2267-2271.
11. National Heart, Lung and Blood Institute: For safety, HNBLI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease 2008. http://www.nihgov/news/health/feb2008/nhlbi-06.htm.
12. Nathan DM, Cleary PA, Backland JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B;Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653.
13. The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572.
14. The Action to Control Cardiovascular Risk in Diabetes Study Group (ACCORD): Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559.
15. American Diabetes Association: Standards of medical care in diabetes 2008. Diabetes Care 2008;31(suppl 1):S12-S54.
16. Burnett RW, Covington AK, Fogh-Anderson N: Recommendations for measurement of and conventions for reporting sodium and potassium by the IFCC Working Group on Selective Electrodes. Clin Chem Lab Med 2000;38:1065-1071.
17. Hillier TA, Abbott RD, Barrett EJ: Hyponatraemia: evaluating the correction factor for hyperglycemia. Am J Med 1999;106:399-403.
18. Katz MA: Hyperglycaemia induced hyponatraemia: calculation of expected serum sodium depression. N Engl J Med 1973;289:843-844.
19. Davenport A: Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients. Nephron Clin Pract 2006;104:120-125.
20. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y; Osaka CKD Expert Research Group: Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol 2007;18:896-903.
21. Yoshiuchi K, Matsuhisa M, Katakami N, Nakatani Y, Sakamoto K, Matsuoka T, Umayahara Y, Kosugi K, Kaneto H, Yamasaki Y, Hori M: Glycated albumin is a better indicator for glucose excursion than glycated haemoglobin in type 1 and type 2 diabetes. Endocr J 2008;55:503-507. (Pubitemid 351949744)
22. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S: Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb versus glycated albumin (GA). J Med Invest 2006;53:223-228. (Pubitemid 44619840)
23. Feldt-Rasmussen B: Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney Int 2006;70:1392-1394.